Answer:
To describe a new specie, it has to be carefully examined in order to determinate that it doesn´t belong to an another specie already described.
Once it has been determinate the novelty of the specie, the researchers write a formal description of it, takes pictures and name it with the new scientific name. Then, the researchers refer it to a scientific magazine. The editor of the publication will comunicate the new discovery to an experts in that gender. If the experts agreed, and the publication accept the study, the specimen converts to a new specie. The process is long and could take years betwen the inicial discovery and the formal acceptation of the new specie
Explanation:
Answer:
This signifies that the protein primarily comprises multiple polypeptide chains connected together with the help of disulfide bonds. The enzymes may be found in the form of dimers, trimers, or tetramers. Various examples of dimers, trimers, and tetramer proteins are known, of them, NEMOs dimers are considered to be held by disulfide bonds.
Thus, it can be hypothesized that the enzyme under examination is a multimer held in combination by disulfide bonds, with each comprising catalytic sites. On breaking of disulfide bonds, the enzyme dissociates into its many single units.
This illustrates the reduction in catalytic activity. Each active site in a single unit will work, however, at a gradual rate. This also shows detection of multiple globular proteins after disulfide reduction.
Answer:
Decrease
Explanation:
Acceleration is inversely proportional to the mass of an object.
Acceleration decrease as the mass of the object increase
If u use the formula F=ma to calculate, you will get
a=0.5m/s2 for the first situation (m=10kg) and a=0.25m/s2 for the second situation (m=20kg)
<u>Stem cell </u>research has the potential to significantly impact the development of disease-modifying treatments for Parkinson’s disease with considerable progress made in creating dopamine-progressing cells.
Explanation:
Parkinson’s disease, a neurodegenerative disease, leads to reduction of dopamine (a neurochemical messenger which carries messages involving thinking and body movements to brain) in the body because the disease will target and kill dopamine-producing nerve cells (neurons). This leads to loss of movement and thinking abilities which are activated by dopamine.
Stem cells research is done to study about the prospects of stem cells in stem cell therapy for Parkinson’s patients as a viable source of new dopamine nerve cells. Research has been involved in growing stem cells to replace or regenerate dopamine-producing nerve cells by using embryonic stem cells or induced pluripotent stem cells as a treatment modality in Parkinson’s disease.
